4/A//SEC Filing
ANGIOTECH PHARMACEUTICALS INC 4/A
Accession 0001096481-09-000027
CIK 0001096481operating
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 7:55 PM ET
Size
14.0 KB
Accession
0001096481-09-000027
Insider Transaction Report
Form 4/AAmended
Richardson Hartley T
Other
Transactions
- Exercise of In-Money
Awards
2009-07-02−5,000→ 93,750 totalExercise: $0.21From: 2008-12-08Exp: 2013-12-07→ Common Stock (5,000 underlying) - Other
Awards
2009-06-09−5,000→ 93,750 totalExercise: $27.75From: 2004-07-01Exp: 2009-06-09→ Common Stock (5,000 underlying) - Exercise of In-Money
Common Stock
2009-07-02$0.21/sh+10,000$2,100→ 1,761,000 total - Other
Awards
2009-06-04−1,250→ 93,750 totalExercise: $3.96From: 2008-01-01Exp: 2012-11-30→ Common Stock (1,250 underlying) - Exercise of In-Money
Awards
2009-07-02−5,000→ 93,750 totalExercise: $0.21From: 2009-01-01Exp: 2013-12-07→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]These awards were canceled on June 4, 2009, when Mr. Richardson ceased being a Director of Angiotech Pharmaceuticals, Inc.
- [F2]These awards expired on June 9, 2009.
Documents
Issuer
ANGIOTECH PHARMACEUTICALS INC
CIK 0001096481
Entity typeoperating
Related Parties
1- filerCIK 0001096481
Filing Metadata
- Form type
- 4/A
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 7:55 PM ET
- Size
- 14.0 KB